← Back to Search

Behavioral Intervention

Behavioral Activation for Serious Mental Illness

N/A
Recruiting
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test a new program to help people with serious mental illness become more active and involved in their communities. Participants will attend weekly online sessions for 10 weeks and then monthly sessions for

Who is the study for?
This trial is for individuals with serious mental illnesses like Schizoaffective Disorder, Schizophrenia, various forms of Depression, Bipolar Disorder, Psychosis, and Mood Disorders. Participants should be willing to engage in online sessions and use a GPS app to track movement.
What is being tested?
The study tests Behavioral Activation intervention aimed at increasing activity variety and community participation among the mentally ill. It involves weekly online sessions for 10 weeks followed by monthly check-ins over three months.
What are the potential side effects?
Since this is a behavioral intervention rather than a medication or medical procedure, traditional side effects are not expected. However, participants may experience changes in mood or stress due to new activities or increased social interactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Activity Logs
Behavior Activation for Depression Scale
Community Mobility (Global Positioning System; GPS)
+2 more
Secondary study objectives
Activity Assessment Scale
Capabilities and Opportunities for Participation Questionnaire
Habit Strength Scale
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention groupExperimental Treatment1 Intervention
All participants will receive an online behavioral intervention for 10 weeks, followed by monthly maintenance sessions for 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavior Activation
2014
N/A
~60

Find a Location

Who is running the clinical trial?

National Institute on Disability, Independent Living, and Rehabilitation ResearchFED
80 Previous Clinical Trials
10,095 Total Patients Enrolled
1 Trials studying Schizophrenia
300 Patients Enrolled for Schizophrenia
Temple UniversityLead Sponsor
316 Previous Clinical Trials
89,240 Total Patients Enrolled
3 Trials studying Schizophrenia
452 Patients Enrolled for Schizophrenia
~34 spots leftby Aug 2026